Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies

The CARRA Registry for Pediatric Rheumatic Diseases

Description:

The CARRA Registry will help monitor the long term safety of current medications being used to treat pediatric rheumatic diseases. By collecting information from thousands of patients to evaluate their treatments, side effects and quality of life.

Learn more here.

Who May Qualify?:

Children and young adults with pediatric rheumatic disease from 2 to 21 years of age.

Who Does Not Qualify:

Patients over 21 years of age.

Interested in participating?

We are currently recruiting

Study Sponsor:

Duke University

Full IRB Study Title:

Observational Study Of Pediatric Rheumatic Diseases: The CARRA Registry

IRB Study ID:

1167543-1

If you are interested in this study or have questions about your child's eligibility, please contact:

Sherry Hillyer, Clinical Research Nurse: 330-543-5853

Jessica Kracker, Clinical Research Nurse: 330-543-0846

Lead Investigator

Kathryn Cook, DO

Director, Division of Rheumatology; Pediatric Rheumatologist
Pediatric RheumatologyVasculitis Clinic

While we are ranked among the best children's hospitals in the country, it's our compassionate approach to treatment that makes us truly exceptional. Through a combination of revolutionary treatments and extraordinary patient experiences, our care does more than heal. It brings the entire family together for emotional support and understanding across multiple locations to reach you in the community where you live. Learn more...